Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis

被引:50
作者
Koike, K [1 ]
Moriya, K [1 ]
Yotsuyanagi, H [1 ]
Shintani, Y [1 ]
Fujie, H [1 ]
Tsutsumi, T [1 ]
Kimura, S [1 ]
机构
[1] Univ Tokyo, Dept Internal Med 1, Bunkyo Ku, Tokyo 1138655, Japan
关键词
hepatitis B virus; HBx gene; apoptosis; hepatocellular carcinoma;
D O I
10.1016/S0304-3835(98)00252-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The HBx protein of hepatitis B virus has been shown to induce hepatocellular carcinoma in transgenic mice as direct evidence for its involvement in hepatocarcinogenesis. In these transgenic mice, however, it is not clear why hepatocytes do not acquire a neoplastic phenotype by 13 months old despite the continuous growth stimulation by the HBx protein from 2 months old. In this study, we show that the accelerated proliferation of hepatocytes is counterbalanced by apoptosis, which maintains liver homeostasis. A decrease in the extent of apoptosis seems to precede the emergence of neoplasia in the transgenic mouse liver. The disappearance or block of apoptotic signals, which may be the result of additional genetic or epigenetic aberrations, may result in the preneoplastic hepatocytes becoming neoplastic. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:181 / 186
页数:6
相关论文
共 27 条
[1]   FULL-LENGTH AND TRUNCATED VERSIONS OF THE HEPATITIS-B VIRUS (HBV) X-PROTEIN (PX) TRANSACTIVATE THE CMYC PROTOONCOGENE AT THE TRANSCRIPTIONAL LEVEL [J].
BALSANO, C ;
AVANTAGGIATI, ML ;
NATOLI, G ;
DEMARZIO, E ;
WILL, H ;
PERRICAUDET, M ;
LEVRERO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (03) :985-992
[2]   HEPATITIS-B VIRUS HBX PROTEIN DEREGULATES CELL-CYCLE CHECKPOINT CONTROLS [J].
BENN, J ;
SCHNEIDER, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :11215-11219
[3]  
BURSCH W, 1985, VIRCHOWS ARCH B, V50, P153
[4]  
BURSCH W, 1984, CARCINOGENESIS, V5, P543
[5]   The hepatitis B virus X gene induces p53-mediated programmed cell death [J].
Chirillo, P ;
Pagano, S ;
Natoli, G ;
Puri, PL ;
Burgio, VL ;
Balsano, C ;
Levrero, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8162-8167
[6]  
COLUMBANO A, 1985, LAB INVEST, V52, P670
[7]   HEPATITIS-B X-GENE EXPRESSION IN HEPATOCELLULAR-CARCINOMA [J].
DIAMANTIS, ID ;
MCGANDY, CE ;
CHEN, TJ ;
LIAW, YF ;
GUDAT, F ;
BIANCHI, L .
JOURNAL OF HEPATOLOGY, 1992, 15 (03) :400-403
[8]  
FEITELSON MA, 1993, ONCOGENE, V8, P1109
[9]   IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501
[10]   T-ANTIGEN EXPRESSION AND TUMORIGENESIS IN TRANSGENIC MICE CONTAINING A MOUSE MAJOR URINARY PROTEIN/SV40 T-ANTIGEN HYBRID GENE [J].
HELD, WA ;
MULLINS, JJ ;
KUHN, NJ ;
GALLAGHER, JF ;
GU, GGD ;
GROSS, KW .
EMBO JOURNAL, 1989, 8 (01) :183-191